News

Neurizon’s ALS drug shows safety and extended survival in open-label extension study

Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

MND left her without a voice. Eight seconds of scratchy audio gave it back to her

The onset of motor neurone disease (MND) left Sarah without a voice and the use of her hands at the age of 34. It was within ...